keyword
https://read.qxmd.com/read/38630291/comparative-performance-of-scfv-based-anti-bcma-car-formats-for-improved-t-cell-therapy-in-multiple-myeloma
#1
JOURNAL ARTICLE
Sophia Stock, Luisa Fertig, Adrian Gottschlich, Janina Dörr, Florian Märkl, Lina Majed, Vivien D Menkhoff, Ruth Grünmeier, Kai Rejeski, David M Cordas Dos Santos, Sebastian Theurich, Michael von Bergwelt-Baildon, Stefan Endres, Marion Subklewe, Sebastian Kobold
In multiple myeloma (MM), B cell maturation antigen (BCMA)-directed CAR T cells have emerged as a novel therapy with potential for long-term disease control. Anti-BCMA CAR T cells with a CD8-based transmembrane (TM) and CD137 (41BB) as intracellular costimulatory domain are in routine clinical use. As the CAR construct architecture can differentially impact performance and efficacy, the optimal construction of a BCMA-targeting CAR remains to be elucidated. Here, we hypothesized that varying the constituents of the CAR structure known to impact performance could shed light on how to improve established anti-BCMA CAR constructs...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630258/associations-of-granulocyte-colony-stimulating-factor-with-toxicities-and-efficacy-of-chimeric-antigen-receptor-t-cell-therapy-in-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia
#2
JOURNAL ARTICLE
Sha Ma, Ying Wang, Kunming Qi, Wenyi Lu, Yuekun Qi, Jiang Cao, Mingshan Niu, Depeng Li, Wei Sang, Zhiling Yan, Feng Zhu, Hai Cheng, Zhenyu Li, Mingfeng Zhao, Kailin Xu
Few studies have reported the associations of granulocyte colony-stimulating factor (G-CSF) with cytokine release syndrome (CRS), neurotoxic events (NEs) and efficacy after chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). We present a retrospective study of 67 patients with R/R B-ALL who received anti-CD19 CAR T-cell therapy, 41 (61.2%) patients received G-CSF (G-CSF group), while 26 (38.8%) did not (non-G-CSF group). Patients had similar duration of grade 3-4 neutropenia between the two groups...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630156/anti-obesity-potentiality-of-lactiplantibacillus-plantarum-e2_mcckt-isolated-from-a-fermented-beverage-haria-a-high-fat-diet-induced-obese-mice-model-study
#3
JOURNAL ARTICLE
Tridip Kumar Das, Priyanka Kar, Titli Panchali, Amina Khatun, Ananya Dutta, Smita Ghosh, Sudipta Chakrabarti, Shrabani Pradhan, Keshab Chandra Mondal, Kuntal Ghosh
Obesity is a growing epidemic worldwide. Several pharmacologic drugs are being used to treat obesity but these medicines exhibit side effects. To find out the alternatives of these drugs, we aimed to assess the probiotic properties and anti-obesity potentiality of a lactic acid bacterium E2_MCCKT, isolated from a traditional fermented rice beverage, haria. Based on the 16S rRNA sequencing, the bacterium was identified as Lactiplantibacillus plantarum E2_MCCKT. The bacterium exhibited in vitro probiotic activity in terms of high survivability in an acidic environment and 2% bile salt, moderate auto-aggregation, and hydrophobicity...
April 17, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38628495/immunomodulatory-associated-gene-transcripts-to-multipotency-of-bovine-amniotic-fluid-mesenchymal-stem-cells
#4
JOURNAL ARTICLE
Jamila Cristina Baptistella, Carolina Gonzales da Silva, Sônia Nair Báo, Letícia Colin Panegossi, Tereza Cristina Cardoso, Roberto Gameiro de Carvalho, Carlos Frederico Martins
The adnexa fetal tissues are sources of mesenchymal stromal cells (MSCs) due to their noninvasive harvest, with all biological material discarded most of the time. MSCs are a promise regarding to their plasticity, self-renewal, differentiation potentials, immunomodulatory and anti-inflammatory properties, which have made clinical stem cell therapy a reality. The present study aimed to characterize and evaluate the immunomodulation ability of bovine mesenchymal cells collected from bovine amniotic fluid (bAFMSCs) isolated and subjected to sixth consecutive culture passages in vitro ...
2024: Animal Reproduction
https://read.qxmd.com/read/38628287/exploring-the-efficacy-and-safety-of-anti-bcma-chimeric-antigen-receptor-t-cell-therapy-for-multiple-myeloma-systematic-review-and-meta-analysis
#5
JOURNAL ARTICLE
Jia Zhang, Xinhua Ding, Xiaoxiao Ding
OBJECTIVE: Multiple myeloma (MM) is a bone marrow cancer that profoundly affects plasma cells involved in the immune response. Myeloma cells alter the average production of cells in the bone marrow. Anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy allows genetic modifications of an individual's T-cells to increase the expression of CARs used to identify and attach BCMA proteins to the malignant cells. Our main objective is to perform a systematic review and meta-analysis to explore the efficacy and safety of anti-BCMA CAR T-cell therapy for MM...
2024: CytoJournal
https://read.qxmd.com/read/38627097/lysophosphatidic-acid-receptor-1-plays-a-pathogenic-role-in-permanent-brain-ischemic-stroke-by-modulating-neuroinflammatory-responses
#6
JOURNAL ARTICLE
Supriya Tiwari, Nikita Basnet, Ji Woong Choi
Lysophosphatidic acid receptor 1 (LPA1 ) plays a critical role in brain injury following a transient brain ischemic stroke. However, its role in permanent brain ischemic stroke remains unknown. To address this, we investigated whether LPA1 could contribute to brain injury of mice challenged by permanent middle cerebral artery occlusion (pMCAO). A selective LPA1 antagonist (AM152) was used as a pharmacological tool for this investigation. When AM152 was given to pMCAO-challenged mice one hour after occlusion, pMCAO-induced brain damage such as brain infarction, functional neurological deficits, apoptosis, and blood-brain barrier disruption was significantly attenuated...
April 17, 2024: Biomolecules & Therapeutics
https://read.qxmd.com/read/38622139/intention-to-treat-outcomes-utilising-a-stringent-event-definition-in-children-and-young-people-treated-with-tisagenlecleucel-for-r-r-all-through-a-national-access-scheme
#7
JOURNAL ARTICLE
Macarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, Denise Bonney, Kelly Watts, Geoff Shenton, Katarzyna A Jalowiec, Maeve A O'Reilly, Claire Roddie, Anna Castleton, Katherine Clesham, Emma Nicholson, Rajesh Alajangi, Shilpa Prabhu, Lindsay George, Ben Uttenthal, Maria Gabelli, Lorna Neill, Caroline Besley, Sridhar Chaganti, Robert F Wynn, Jack Bartram, Robert Chiesa, Giovanna Lucchini, Vesna Pavasovic, Anupama Rao, Kanchan Rao, Juliana Silva, Sujith Samarasinghe, Ajay Vora, Peter Clark, Michelle Cummins, David I Marks, Persis Amrolia, Rachael Hough, Sara Ghorashian
CAR T-cell therapy has transformed relapsed/refractory (r/r) B-cell precursor acute lymphoblastic leukaemia (B-ALL) management and outcomes, but following CAR T infusion, interventions are often needed. In a UK multicentre study, we retrospectively evaluated tisagenlecleucel outcomes in all eligible patients, analysing overall survival (OS) and event-free survival (EFS) with standard and stringent definitions, the latter including measurable residual disease (MRD) emergence and further anti-leukaemic therapy...
April 15, 2024: Blood Cancer Journal
https://read.qxmd.com/read/38616634/-chimeric-antigen-receptor-t-cells-car-t-cells-therapy-for-b-cell-hematological-malignancies-from-the-israeli-society-of-hematology-and-transfusion-medicine
#8
JOURNAL ARTICLE
Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, Liat Shargian, Elad Jacoby, Sigal Grisaru, Tsila Zuckerman, Ron Ram, Abraham Avigdor
Using immunotherapy to fight cancer, and specifically, the use of engineered T-cells expressing a chimeric receptor against an antigen found on malignant cells (chimeric antigen receptor, CAR-T cells) constitutes a significant breakthrough in the treatment of the disease. In recent years, several CAR-T therapies have been approved in Europe and the USA, and some are already approved and funded through the national health basket in Israel, for the indications of diffuse large B-cell lymphoma, mantle cell lymphoma and B-cell acute lymphoblastic leukemia, after the failure of at least two lines of treatment...
April 2024: Harefuah
https://read.qxmd.com/read/38615384/analysis-of-the-sodium-pump-subunit-atp1a3-in-glioma-patients-potential-value-in-prognostic-prediction-and-immunotherapy
#9
JOURNAL ARTICLE
Yu-Long Lan, Shuang Zou, Bing Qin, Xiangdong Zhu
The ATP1A3 gene is associated with the development and progression of neurological diseases. However, the pathological function and therapeutic value of ATP1A3 in glioblastoma (GBM) remains unknown. In this study, we tried to explore the correlation between the ATP1A3 gene expression and immune features in GBM samples. We found that ATP1A3 gene expression levels showed significant negative correlation with immune checkpoints such as PD-L1, CTLA-4 and IDO1. Next, ATP1A3 gene expression levels showed significant negative correlation with the anti-cancer immune cell process, the immune score and stromal score...
April 13, 2024: International Immunopharmacology
https://read.qxmd.com/read/38615380/anlotinib-may-enhance-the-efficacy-of-anti-pd1-therapy-by-inhibiting-the-akt-pathway-and-promoting-the-apoptosis-of-cafs-in-lung-adenocarcinoma
#10
JOURNAL ARTICLE
Hui Tang, Tingting You, Hui Ge, Jingxi Gao, Yingyi Wang, Chunmei Bai, Zhao Sun, Qin Han, Robert Chunhua Zhao
Although PD-1 inhibitors have revolutionized the treatment paradigm of non-small cell lung cancer (NSCLC), their efficacy in treating NSCLC has remained unsatisfactory. Targeting cancer-associated fibroblasts (CAFs) is a potential approach for improving the immunotherapy response. Multitarget antiangiogenic tyrosine kinase receptor inhibitors (TKIs) can enhance the efficacy of PD-1 inhibitors in NSCLC patients. However, the effects and mechanisms of antiangiogenic TKIs on CAFs have not been elucidated. In this study, we first compared anlotinib with other antiangiogenic TKIs and confirmed the superior efficacy of anlotinib...
April 12, 2024: International Immunopharmacology
https://read.qxmd.com/read/38613673/paradoxical-effect-of-anti-inflammatory-drugs-on-il-6-mrna-expression-in-patients-with-ptsd-during-treatment
#11
JOURNAL ARTICLE
Cosima Rhein, Isabella Apelt, Franziska Werner, Eva Schäflein, Werner Adler, Martin Reichel, Caterina Schug, Eva Morawa, Yesim Erim
The pathophysiology of posttraumatic stress disorder (PTSD) is associated with the activation of the innate immune system, including cytokines like interleukin 6 (IL-6). However, the role of IL-6 in the etiology and treatment of PTSD still remains elusive. We conducted a prospective controlled trial to investigate the development of IL-6 during psychosomatic treatment in individuals with PTSD in comparison with individuals without PTSD. We assessed IL-6 mRNA expression before and after 2 months of psychosomatic treatment in individuals with and without PTSD...
April 13, 2024: Journal of Neural Transmission
https://read.qxmd.com/read/38613657/comprehensive-risk-factor-predictions-for-3-year-survival-among-hiv-associated-and-disseminated-cryptococcosis-involving-lungs-and-central-nervous-system
#12
JOURNAL ARTICLE
Luling Wu, Xuemin Fu, Benno Pütz, Renfang Zhang, Li Liu, Wei Song, Ling Weng, Yueming Shao, Zhihang Zheng, Jingna Xun, Ximei Han, Ting Wang, Yinzhong Shen, Hongzhou Lu, Bertram Müller-Myhsok, Jun Chen
BACKGROUND: The global mortality rate resulting from HIV-associated cryptococcal disease is remarkably elevated, particularly in severe cases with dissemination to the lungs and central nervous system (CNS). Regrettably, there is a dearth of predictive analysis regarding long-term survival, and few studies have conducted longitudinal follow-up assessments for comparing anti-HIV and antifungal treatments. METHODS: A cohort of 83 patients with HIV-related disseminated cryptococcosis involving the lung and CNS was studied for 3 years to examine survival...
April 13, 2024: Infection
https://read.qxmd.com/read/38612615/possible-role-of-cannabis-in-the-management-of-neuroinflammation-in-patients-with-post-covid-condition
#13
REVIEW
Noemi Cárdenas-Rodríguez, Iván Ignacio-Mejía, Jose Correa-Basurto, Humberto Carrasco-Vargas, Marco Antonio Vargas-Hernández, Exal Manuel Albores-Méndez, Rodolfo David Mayen-Quinto, Reynita De La Paz-Valente, Cindy Bandala
The post-COVID condition (PCC) is a pathology stemming from COVID-19, and studying its pathophysiology, diagnosis, and treatment is crucial. Neuroinflammation causes the most common manifestations of this disease including headaches, fatigue, insomnia, depression, anxiety, among others. Currently, there are no specific management proposals; however, given that the inflammatory component involves cytokines and free radicals, these conditions must be treated to reduce the current symptoms and provide neuroprotection to reduce the risk of a long-term neurodegenerative disease...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612528/genetic-variants-associated-with-biological-treatment-response-in-inflammatory-bowel-disease-a-systematic-review
#14
REVIEW
Javier Plaza, Alejandro Mínguez, Guillermo Bastida, Remedios Marqués, Pilar Nos, Jose Luis Poveda, Inés Moret-Tatay
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the digestive tract usually characterized by diarrhea, rectal bleeding, and abdominal pain. IBD includes Crohn's disease and ulcerative colitis as the main entities. IBD is a debilitating condition that can lead to life-threatening complications, involving possible malignancy and surgery. The available therapies aim to achieve long-term remission and prevent disease progression. Biologics are bioengineered therapeutic drugs that mainly target proteins...
March 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612407/mrna-lnp-covid-19-vaccine-lipids-induce-complement-activation-and-production-of-proinflammatory-cytokines-mechanisms-effects-of-complement-inhibitors-and-relevance-to-adverse-reactions
#15
JOURNAL ARTICLE
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, Petra Berényi, Réka Facskó, Henriette Farkas, László Dézsi, Carlo Heirman, Stefaan de Koker, Raymond Schiffelers, Kathryn Anne Glatter, Tamás Radovits, Gábor Szénási, János Szebeni
A small fraction of people vaccinated with mRNA-lipid nanoparticle (mRNA-LNP)-based COVID-19 vaccines display acute or subacute inflammatory symptoms whose mechanism has not been clarified to date. To better understand the molecular mechanism of these adverse events (AEs), here, we analyzed in vitro the vaccine-induced induction and interrelations of the following two major inflammatory processes: complement (C) activation and release of proinflammatory cytokines. Incubation of Pfizer-BioNTech's Comirnaty and Moderna's Spikevax with 75% human serum led to significant increases in C5a, sC5b-9, and Bb but not C4d, indicating C activation mainly via the alternative pathway...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610966/asciminib-maintains-antibody-dependent-cellular-cytotoxicity-against-leukemic-blasts
#16
JOURNAL ARTICLE
Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
B cell acute lymphoblastic leukemia (B-ALL) is characterized by an accumulation of malignant precursor cells. Treatment consists of multiagent chemotherapy followed by allogeneic stem cell transplantation in high-risk patients. In addition, patients bearing the BCR-ABL1 fusion gene receive concomitant tyrosine kinase inhibitor (TKI) therapy. On the other hand, monoclonal antibody therapy is increasingly used in both clinical trials and real-world settings. The introduction of rituximab has improved the outcomes in CD20 positive cases...
March 26, 2024: Cancers
https://read.qxmd.com/read/38608474/esculin-suppresses-the-perk-eif2%C3%AE-chop-pathway-by-enhancing-sirt1-expression-in-oxidative-stress-induced-rat-chondrocytes-mitigating-osteoarthritis-progression-in-a-rat-model
#17
JOURNAL ARTICLE
Zhihua Cheng, Zheyuan Liu, Chao Liu, Aoxiang Yang, Haichuan Miao, Xizhuang Bai
OBJECTIVE: Osteoarthritis (OA) is a degenerative disease characterized by the gradual degeneration of chondrocytes, involving endoplasmic reticulum (ER) stress. Esculin is a natural compound with antioxidant, anti-inflammatory and anti-tumor properties. However, its impact on ER stress in OA therapy has not been thoroughly investigated. We aim to determine the efficiency of Esculin in OA treatment and its underlying mechanism. METHODS: We utilized the tert-butyl hydroperoxide (TBHP) to establish OA model in chondrocytes...
April 11, 2024: International Immunopharmacology
https://read.qxmd.com/read/38607144/gentiopicrin-loaded-chitosan-nanoparticles-as-a-topical-agent-for-the-treatment-of-psoriasis
#18
JOURNAL ARTICLE
Guohua Cheng, Xiaojie Zhang, Huiling Zhang, Zhixuan Feng, Jiaxiu Cai, Jingjing Li, Libo Du, Ke Liu
Psoriasis, a chronic inflammatory skin disease induced by various factors, including genetic factors, immune factors, environmental factors, and psychological factors, is characterized by thickening of the epidermis, excessive proliferation of keratinocytes, abnormal differentiation, and an excessive inflammatory response. Traditional treatments for psoriasis still face challenges because of limited curative effects, notable side effects, and a tendency for recurrence. In contrast, topical therapy provides a favorable option for psoriasis treatment because of its noninvasive and self-administered method...
March 29, 2024: Nanomaterials
https://read.qxmd.com/read/38606818/clinical-characterization-of-hemophagocytic-lymphohistiocytosis-caused-by-immune-checkpoint-inhibitors-a-review-of-published-cases
#19
REVIEW
Zhiya Xu, Huilan Li, Xinyi Yu, Jia Luo, Zanling Zhang
OBJECTIVE: An association exists between immune checkpoint inhibitors and hemophagocytic lymphohistiocytosis (HLH). Therefore, the main objective of this study was to collect data on this rare but potentially life-threatening immune-related adverse reaction to identify the medications that cause it, the clinical characteristics, and effective treatments. METHODS: Literature in English and Chinese on immune checkpoint inhibitors causing HLH published from August 2014 to March 2024 was analyzed...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38606791/molecular-and-pathophysiological-relationship-between-obesity-and-chronic-inflammation-in-the-manifestation-of-metabolic-dysfunctions-and-their-inflammation%C3%A2-mediating-treatment-options-review
#20
JOURNAL ARTICLE
Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis-Nobelos
Obesity reaches up to epidemic proportions globally and increases the risk for a wide spectrum of co‑morbidities, including type‑2 diabetes mellitus (T2DM), hypertension, dyslipidemia, cardiovascular diseases, non‑alcoholic fatty liver disease, kidney diseases, respiratory disorders, sleep apnea, musculoskeletal disorders and osteoarthritis, subfertility, psychosocial problems and certain types of cancers. The underlying inflammatory mechanisms interconnecting obesity with metabolic dysfunction are not completely understood...
June 2024: Molecular Medicine Reports
keyword
keyword
108332
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.